[BolliBatlu]

Countries with compulsory TB vaccine BCG like India are showing fewer Covid-19 deaths

These ‘disease hunters’ developed a novel technique for tracking pandemics after 9/11, but lost funding right before COVID-19
New Study on Covid-19 by British Doctors Links Loss of Smell to Infection

Korea’s response to Covid-19 was widely praised. Startups had a lot to do with it
South Korea turns to tech to take on Covid-19

Israeli Bio-Defense Lab Reports 'Significant Progress' On Corona Virus Vaccine

Explained: Why researchers have developed the musical structure of COVID-19

Anti-parasitic drug Ivermectin can kill COVID-19 coronavirus within 48 hours, claim Australian scientists

STAT’s guide to how hospitals are using AI to fight Covid-19
Updated: This AI camera detects people who may have COVID-19

Coconut against COVID-19? 2

‘Coronascope’ enables live observations of COVID-19 infections

British Indian entrepreneur's firm begins arthritis drug tests for COVID-19

Robots may become heroes in war against COVID-19

How Covid-19 has created revenue opportunities for tech businesses adopting this unique approach

Can We Have Access and, Not Versus, Innovation for COVID-19 Treatments?

COVID-19: 42 Vaccines in Pre-Clinical Stage; Two in Phase 1, Reveals WHO

Comparison: COVID-19 Innovations in the U.S. Versus the Rest of the World

Amidst Covid-19 Pandemic, CDC Wants To Hire A Chief Data Officer

Facebook expands location sharing data by providing it to Covid researchers
Google, Facebook Share Mobile Location Data for COVID-19 Efforts
Government, researchers and big tech team up for digital COVID-19 tools

UK doctors to research more severe COVID-19 impact on Indians
Hawaii researchers seek clues to COVID-19 risk in DNA

Second US study for COVID-19 vaccine uses skin-deep shots

Care Access Research Launches COVID-19 Clinical Trials Alliance to Accelerate Vaccine and Drug Development

Coronavirus may ‘reactivate’ in cured patients: Korean CDC

Wuhan hospital says HIV drug beneficial to Covid-19 patients
Swedish hospitals abandon trial of promising malaria drug chloroquine for coronavirus patients after it caused them blinding headaches, vision loss and agonising cramps

So, Indian companies' plan to ramp up production has to be relooked into.

Active Motif launches a portfolio of recombinant COVID-19 antibodies; the first full human antibodies derived from patients infected with the 2019 Coronavirus, now available for research and commercial use